Cohen Fred E Insider Trades

Insider Trading History

Track insider trading activity for Cohen Fred E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $3.3M 216,653 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$15.25
Kyverna Therapeutics
Kyverna Therapeutics KYTX
Director
Holding Value $183k 21,727 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 25,675 shares
$8.59
$8.43
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $3.16M 207,453 shares
Last Trade
Jan 05, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.4M 150,000 shares
$9.35
$15.25
Caredx
Caredx CDNA
Director
Holding Value $3.9M 155,265 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 12,103 shares
$18.59
$25.12
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $876k 57,453 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95.8k 11,450 shares
$8.37
$15.25
Kyverna Therapeutics
Kyverna Therapeutics KYTX
10% owner
Holding Value $551k 65,351 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$172k 65,351 shares
$2.63
$8.43
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $352k 10,000 shares
Last Trade
Aug 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$152k 10,000 shares
$15.16
$35.15
Caredx
Caredx CDNA
Director
Holding Value $3.6M 143,162 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$228k 16,048 shares
$14.19
$25.12
Caredx
Caredx CDNA
Director
Holding Value $403k 16,048 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$228k 16,048 shares
$14.19
$25.12
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $754k 49,453 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$298k 11,515 shares
$25.85
$15.25
Progyny
Progyny PGNY
Director
Holding Value $668k 25,070 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$681k 25,070 shares
$27.15
$26.63
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $352k 10,000 shares
Last Trade
Sep 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 10,000 shares
$16.85
$35.15
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $2.44M 69,339 shares
Last Trade
Jul 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$661k 69,339 shares
$9.54
$35.15
Caredx
Caredx CDNA
Director
Holding Value $3.33M 132,592 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$232k 29,136 shares
$7.96
$25.12
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $636k 41,716 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$293k 6,473 shares
$45.20
$15.25
Progyny
Progyny PGNY
Director
Holding Value $489k 18,350 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$702k 18,350 shares
$38.24
$26.63
Caredx
Caredx CDNA
Director
Holding Value $2.86M 113,748 shares
Last Trade
Jan 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.9k 1,062 shares
$11.24
$25.12
Caredx
Caredx CDNA
Director
Holding Value $2.83M 112,686 shares
Last Trade
Oct 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.8k 803 shares
$18.45
$25.12
Caredx
Caredx CDNA
Director
Holding Value $2.81M 111,883 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$256k 12,469 shares
$20.56
$25.12
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $569k 37,291 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 5,197 shares
$38.49
$15.25

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up